P

Assignee

CYTOGEN CORP

US28 patents

Top patents by PatentIndex Score

US5449761ASep 12, 1995

Metal-binding targeted polypeptide constructs

CYTOGEN CORP111 citations98
US5326856AJul 5, 1994

Bifunctional isothiocyanate derived thiocarbonyls as ligands for metal binding

CYTOGEN CORP152 citations98
US4671958AJun 9, 1987

Antibody conjugates for the delivery of compounds to target sites

CYTOGEN CORP958 citations98
US5196510AMar 23, 1993

Molecular recognition units

CYTOGEN CORP144 citations97
US5156840AOct 20, 1992

Amine-containing porphyrin derivatives

CYTOGEN CORP182 citations97
US5140104AAug 18, 1992

Amine derivatives of folic acid analogs

CYTOGEN CORP136 citations97
US4867973ASep 19, 1989

Antibody-therapeutic agent conjugates

CYTOGEN CORP440 citations97
US4741900AMay 3, 1988

Antibody-metal ion complexes

CYTOGEN CORP708 citations97
US5885577AMar 23, 1999

Antigen binding peptides (abtides) from peptide libraries

CYTOGEN CORP63 citations96
US5593656AJan 14, 1997

Metal-binding targeted polypeptide constructs

CYTOGEN CORP45 citations96
US5585468ADec 17, 1996

Substituted thioureas as bifunctional chelators

CYTOGEN CORP45 citations96
US5578288ANov 26, 1996

Metal-binding targeted polypeptide constructs

CYTOGEN CORP37 citations96
US5527885AJun 18, 1996

Bifunctional isothiocyanate derived thiocarbonyls as ligands for metal binding

CYTOGEN CORP72 citations96
US5763202AJun 9, 1998

Methods of detecting prostate carcinoma using a monoclonal antibody to a new antigenic marker in epithelial prostatic cells alone or with a monoclonal antibody to an antigen of LNCaP cells

CYTOGEN CORP101 citations95
US5162504ANov 10, 1992

Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients

CYTOGEN CORP320 citations95
US5162512ANov 10, 1992

Amine derivatives of anthracycline antibodies

CYTOGEN CORP55 citations94
US4950738AAug 21, 1990

Amine derivatives of anthracycline antibiotics

CYTOGEN CORP87 citations94
US6703362B1Mar 9, 2004

Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods

CYTOGEN CORP53 citations93
US4937183AJun 26, 1990

Method for the preparation of antibody-fragment conjugates

CYTOGEN CORP62 citations93
US6015561AJan 18, 2000

Antigen binding peptides (abtides) from peptide libraries

CYTOGEN CORP19 citations92
US5578484ANov 26, 1996

Hybridoma and monoclonal antibody 9H10-A4 specific to an antigen of LNCaP cells

CYTOGEN CORP64 citations92
US5495042AFeb 27, 1996

Non-alkaline purification of aminophosphonic acids

CYTOGEN CORP30 citations92
US6432920B1Aug 13, 2002

Nck SH3 binding peptides

CYTOGEN CORP36 citations90
US4966999AOct 30, 1990

Radiohalogenated compounds for site specific labeling

CYTOGEN CORP48 citations89
US5047227ASep 10, 1991

Novel and improved antibodies for site specific attachment of compounds

CYTOGEN CORP48 citations88
US5609847AMar 11, 1997

Treatment methods using metal-binding targeted polypeptide constructs

CYTOGEN CORP12 citations73
US7053177B1May 30, 2006

Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods

CYTOGEN CORP8 citations71
US5942210AAug 24, 1999

Methods for lyoprotecting a macromolecule using tricine

CYTOGEN CORP14 citations69